Licorice: A sweet alternative to prevent hyperkalemia in dialysis patients

Kidney International

Volumn 76, Issue 8, 2009, Pages 811-812

  Ferrari, Paolo ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; PLACEBO; POTASSIUM;

CLINICAL TRIAL; ENZYME INHIBITION; GLYCYRRHIZA; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; NOTE; POTASSIUM BLOOD LEVEL; POTASSIUM DEPLETION; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CORTISONE; ENZYME INHIBITORS; FOOD, FORTIFIED; GLYCYRRHETINIC ACID; GLYCYRRHIZA; HUMANS; HYDROCORTISONE; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; POTASSIUM; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349653796     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.282     Document Type: Note

References (10)

1. Shibata S . A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice . Yakugaku Zasshi 2000 ; 120 : 849-862.
2. Henman FD . Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid . Gut 1970 ; 11 : 344-351.
3. Isbrucker RA , Burdock GA . Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin . Regul Toxicol Pharmacol 2006 ; 46 : 167-192.
4. Ferrari P , Bonny O . Forms of mineralocorticoid hypertension . Vitam Horm 2003 ; 66 : 113-156.
5. Ferrari P , Sansonnens A , Dick B et al. In vivo 11 - HSD- 2 activity: variability, salt-sensitivity, and effect of licorice . Hypertension 2001 ; 38 : 1330-1336.
6. Arriza JL , Weinberger C , Cerelli G et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor . Science 1987 ; 237 : 268-275.
7. Farese S , Kruse A , Pasch A et al. Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients . Kidney Int 2009 ; 76 : 877-884.
8. Young MJ , Moussa L , Dilley R et al. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 - hydroxysteroid dehydrogenase inactivation . Endocrinology 2003 ; 144 : 1121-1125.
9. Wilson P , Morgan J , Funder JW et al. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart . Clin Sci (Lond) 2009 ; 116 : 731-739.
10. Osmond JM , Dorrance AM . 11 -hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia . Endocrinology 2009 ; 150 : 713-719.